Pharmaceutical Technology on MSN
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming ...
This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback